Share Facebook Twitter Email A SEER analysis reveals a more than doubling of active surveillance as the initial strategy for intermediate risk prostate cancer, increasing 5% of cases in 2010 to 12% in 2020, primarily among grade group 1 disease. | Ajjawi, JAMA 2024 Active Surveillance
